Butylboronic acid
Butylboronic acid is a competitive soybean urease inhibitor with an IC50 of 2.9 mM and a Ki of 1.5 mM[1].
Product Specifications
CAS Number
[4426-47-5]
UNSPSC
12352211
Hazard Statement
H227, H315, H319, H335
Target
Phosphatase; Urease
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/butylboronic-acid.html
Purity
99.99
Solubility
DMSO : ≥ 200 mg/mL
Smiles
CCCCB(O)O
Molecular Formula
C4H11BO2
Molecular Weight
101.94
Precautions
H227, H315, H319, H335
References & Citations
[1]Sandeep Kumar, et al. Inhibition studies of soybean (Glycine max) urease with heavy metals, sodium salts of mineral acids, boric acid, and boronic acids. J Enzyme Inhib Med Chem. 2010 Oct;25 (5) :646-52.|[2]Nakano T, et al. Butylboronic acid promotes cell proliferation, alkaline phosphatase activity, and expression of GJA1, ALP, and NaBC1 in human dental pulp cells in vitro. Front Dent Med. 2025 Feb 11;6:1518389.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
172112-AF-ML405 100 µL
IgM (AGM1, IGHM, Constant Region of Heavy Chain of IgM, Ig Mu Chain C Region, Immunoglobulin Mu Heavy Chain) (BSA & Azide Free) (MaxLight 405) discontinued
Sign In for Pricing
View Details MBS6168463-01 0.1 mL
TARBP2 (TAR (HIV-1) RNA Binding Protein 2, LOQS, TRBP, TRBP1, TRBP2) (APC)
Sign In for Pricing
View Details